Trial begins for Endologix's aortic aneurysm device

03/5/2013 | American City Business Journals

Endologix is sponsoring a clinical study of its Ventana Fenestrated System, which features two branched stent grafts for maintaining blood flow in the kidneys and a main column to shield the aorta and prevent blood flow in the aneurysm. The FDA-approved trial will test whether the device is safe and effective in patients with pararenal and juxtarenal aortic aneurysms.

View Full Article in:

American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
Center for Improving Value in Healthcare
Denver, CO
Quality Program Manager II, State Programs
Tufts Health Plan
Watertown, MA
Associate Director, Promotion Integrity
Bristol-Myers Squibb
Plainsboro, NJ
Vice President, Medicare Advantage
BCBS-Louisiana
Baton Rouge, LA
Director, Global Integrity and Compliance, Pharmaceuticals
Alcon
Fort Worth, TX